Madison, WI (May 1, 2016) – Imbed Bio announces that it will exhibit at the 2016 Biotechnology Industry Organization (BIO) International Convention in San Francisco, CA from June 6-9, 2016. National Institutes of Health has selected to showcase Imbed Bio as one of its 50 top funded technologies. Imbed will host a kiosk in the Innovation Zone, an area of the exhibition floor that is dedicated to showcasing Small Business Innovation Research (SBIR) grantees.
SBIR grants provide early-stage funding for small businesses, and Imbed Bio currently has a $1.5M SBIR grant from the NIH to develop antimicrobial microfilm dressing with ionic and metallic silver for management of chronic wounds. Ankit Agarwal, PhD (CEO) will attend the convention and introduce company’s technology platform and pipeline products to potential customers, corporate partners and investors. Please contact Ankit Agarwal through the One-on-One Partnering System at the BIO Conference website if you would like to schedule a meeting at BIO 2016.
About Imbed Biosciences Inc.
Imbed Biosciences is a privately held medical device company, located in Madison, WI. Imbed’s vision is to develop next-generation medical devices that can reduce patient pain and costs for management of burns, chronic wounds, hernia meshes, gastro-intestinal defects, and dural membranes. Company has a portfolio of products in development based on its synthetic and biodegradable thin films platform that present bioactive molecules on tissue surfaces to manage wound infections, biofilms, and local pain and promote wound healing.
CEO, Imbed Biosciences Inc.